Adma Biologics
Adma Biologics is a biopharmaceutical company focused on the development, manufacturing, and commercialization of specialty plasma-derived products for the treatment and prevention of infectious diseases and immune deficiencies. Utilizing advanced plasma collection and fractionation technologies, Adma Biologics delivers high-quality immunoglobulin therapies designed to address critical needs in patient care. The company is committed to innovation, quality, and safety across its product portfolio, supporting both healthcare providers and patients. Adma Biologics’ expertise in plasma-derived therapeutics positions it as a trusted partner within the biotechnology and healthcare industries, dedicated to improving health outcomes through reliable and effective biologic solutions.
